AMTI
Price:
$0.263
Market Cap:
$11.01M
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and...[Read more]
Industry
Biotechnology
IPO Date
2020-06-05
Stock Exchange
NASDAQ
Ticker
AMTI
According to Applied Molecular Transport Inc.’s latest financial reports and current stock price. The company's current ROE is -218.56%. This represents a change of 268.77% compared to the average of -59.27% of the last 4 quarters.
The mean historical ROE of Applied Molecular Transport Inc. over the last ten years is -41.46%. The current -218.56% ROE has changed 427.13% with respect to the historical average. Over the past ten years (40 quarters), AMTI's ROE was at its highest in in the December 2019 quarter at 10.97%. The ROE was at its lowest in in the June 2023 quarter at -83.95%.
Average
-41.46%
Median
-48.98%
Minimum
-206.17%
Maximum
67.67%
Discovering the peaks and valleys of Applied Molecular Transport Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 249.83%
Maximum Annual ROE = 67.67%
Minimum Annual Increase = -225.23%
Minimum Annual ROE = -206.17%
Year | ROE | Change |
---|---|---|
2022 | -206.17% | 249.83% |
2021 | -58.94% | 20.33% |
2020 | -48.98% | -225.23% |
2019 | 39.11% | -42.20% |
The current ROE of Applied Molecular Transport Inc. (AMTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-104.70%
5-year avg
-41.46%
10-year avg
-41.46%
Applied Molecular Transport Inc.’s ROE is less than Catalyst Biosciences, Inc. (1.20%), greater than Aileron Therapeutics, Inc. (-47.94%), greater than Bio-Path Holdings, Inc. (-2842.40%), greater than Benitec Biopharma Inc. (-90.14%), less than Aerovate Therapeutics, Inc. (0%), greater than Adagene Inc. (-83.65%), greater than Acrivon Therapeutics, Inc. Common Stock (-50.10%), greater than Rezolute, Inc. (-47.31%), greater than AN2 Therapeutics, Inc. (-70.73%), greater than Inhibikase Therapeutics, Inc. (-54.72%), less than Sio Gene Therapies Inc. (0%), greater than Kaleido Biosciences, Inc. (-194.17%), greater than Tempest Therapeutics, Inc. (-13.69%), less than Lipella Pharmaceuticals Inc. (0%), greater than Senti Biosciences, Inc. (-201.10%), greater than Fennec Pharmaceuticals Inc. (-39095.64%), greater than Monopar Therapeutics Inc. (-91.09%), greater than null (-52.10%), greater than null (-110.60%),
Company | ROE | Market cap |
---|---|---|
1.20% | $19.42M | |
-47.94% | $86.66M | |
-2842.40% | $3.64M | |
-90.14% | $216.38M | |
0% | $80.54M | |
-83.65% | $146.79M | |
-50.10% | $248.09M | |
-47.31% | $307.60M | |
-70.73% | $32.23M | |
-54.72% | $177.39M | |
0% | $30.70M | |
-194.17% | $4.26K | |
-13.69% | $24.16M | |
0% | $3.12M | |
-201.10% | $9.98M | |
-39095.64% | $118.74M | |
-91.09% | $75.24M | |
-52.10% | $0 | |
-110.60% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Molecular Transport Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Applied Molecular Transport Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Applied Molecular Transport Inc.'s ROE?
How is the ROE calculated for Applied Molecular Transport Inc. (AMTI)?
What is the highest ROE for Applied Molecular Transport Inc. (AMTI)?
What is the 3-year average ROE for Applied Molecular Transport Inc. (AMTI)?
What is the 5-year average ROE for Applied Molecular Transport Inc. (AMTI)?
How does the current ROE for Applied Molecular Transport Inc. (AMTI) compare to its historical average?